Terumo Corporation announced that it has resolved at the Board of Directors held on December 14, 2023 to change the Executive Officers as. Shinjiro Sato's designation will be changed from President and CEO to Director and Corporate Advisor. Shinjiro Sato, with completion of his term, is planned to leave the director's position at the Annual General Meeting of Shareholders to be held on June 26, 2024, and to remain as corporate advisor.

Hikaru Samejima's designation will be changed from Group Senior Managing Executive, Officer President, Medical Care Solutions Company to President and CEO. Hikaru Samejima, is planned to be elected as a candidate of director for the next term at the Board of Directors to be held on February 7, 2024. Subsequently, he is planned to be elected as a Representative Director after getting approval to be a Director at the Annual General Meeting of Shareholders to be held on June 26, 2024.